The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...
Vertex Pharmaceuticals (NASDAQ:VRTX) ended a four-day winning streak on Thursday after UnitedHealth (NYSE:UNH) placed its new ...
Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...
Hosted on MSN1mon
FDA approves Vertex non-opioid pain drugWhat we're watching: It's still an open question whether insurers will cover Journavx. The company has received positive feedback from commercial payers. Vertex is determining whether recent state ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results